Clovis Oncology
CLVS
#10877
Rank
NZ$21.45 M
Marketcap
NZ$0.15
Share price
0.00%
Change (1 day)
-94.96%
Change (1 year)

EPS for Clovis Oncology (CLVS)

EPS in 2022 (TTM): NZ-$2.94

According to Clovis Oncology's latest financial reports the company's current EPS (TTM) is NZ-$3.44. In 2012 the company made an earnings per share (EPS) of NZ-$5.45.

EPS history for Clovis Oncology from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ-$2.94
2012NZ-$5.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.17-453.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.29-137.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$10.66-409.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.30-1,734.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.98-476.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
NZ-$0.16-95.24%๐Ÿ‡บ๐Ÿ‡ธ USA